Iovance Biotherapeutics
Jackie Holcomb (Suzuki) is a highly experienced finance professional who has held various leadership positions in finance and accounting at reputable companies such as Iovance Biotherapeutics, Acerta Pharma B.V., and ChemoCentryx. Jackie has a strong background in financial planning, reporting, and strategic analysis. With a solid academic background including a Master's degree in Accounting from the University of South Carolina Darla Moore School of Business, Jackie brings a wealth of knowledge and expertise to their role.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.